| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5899188 | Diabetes Research and Clinical Practice | 2015 | 9 Pages |
Abstract
In Asian adults with T2DM, IDegAsp BID effectively improves long-term glycaemic control, and compared to BIAsp 30, provides superior reductions in FPG with a lower dose, and numerically less nocturnal hypoglycaemia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Shizuka Kaneko, Francis Chow, Dong Seop Choi, Shinji Taneda, Koichi Hirao, Yongsoo Park, Thomas Hasseriis Andersen, Mari-Anne Gall, Jens Sandahl Christiansen,